Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis

Fig. 3

Bioinformatics data of OSBPL3 overexpression promoting CRC progression. a Pan-cancer analysis of mRNA expression of OSBPL3 in TCGA database, Colon and rectal cancers tissues and normal tissues are highlighted in yellow boxes respectively, the results are significantly different (***P < 0.001). b Differences in mRNA expression of OSBPL3 in normal intestinal tissues and tumor tissues in TCGA database (**P < 0.01). c Differences in protein expression of OSBPL3 in normal tissues and tumor tissues in GPTAC database (**P < 0.01). d Differences in overall survival time of CRC patients between high and low OSBPL3 expression (**P < 0.01)

Back to article page